Abstract
Pelvic recurrence of colorectal cancer (PRCRC) is a common problem after curative colorectal resection for colorectal adenocarcinoma, even in the neoadjuvant treatment age, with an incidence varying between 5% and 50% [1, 2]. Although there have been distinct improvements of therapeutic algorithms in managing systemic hepatic and pulmonary colorectal metastasis, there is no general acceptance of the same radical approach for isolated locally recurrent rectal cancer (LRRC) [3, 4]. In the absence of any treatment, survival of patients with PRCRC is poor and is associated with severe and unpleasant symptoms, such as pain, rectal bleeding, bowel or ureter occlusion, tenesmus, enterocutaneous fistulas, and ulcerating skin lesions [1]. Palliative radiotherapy (RT) alone or in combination with chemotherapy can achieve temporary symptomatic improvement in the majority of patients, but 5-year survival is usually <5% [5, 6]. Palliative surgery can prolong survival, but exposes the patient to substantial postoperative morbidity/mortality [5, 6]. Complete surgical resection with clear circumferential and distal margins (R0), in association with multimodal treatment (preoperative radiochemotherapy or intraoperative RT), remains the best option for cure after a PRCRC. The reported 5-year survival rates vary from 22 to 58% after obtaining R0 resection [7–9]. Therefore, it is essential to: (1) predict failure patterns, and (2) accurately stratify prognosis in relation to the different planned treatments so that appropriate therapy can be selected and proposed. This chapter discusses oncological outcomes of patients with PRCRC resulting from different treatment types.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pacelli F, Tortorelli AP, Rosa F et al (2010) Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 17:152–162
Caricato M, Borzomati D, Ausania F et al (2006) Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 32:126–132
Hahnloser D, Nelson H, Gunderson LL et al (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502–508
Hansen MH, Balteskard L, Dørum LM et al (2009) Norwegian Colorectal Cancer Group. Locally recurrent rectal cancer in Norway. Br J Surg 96:1176–1182
Hashiguchi Y, Sekine T, Sakamoto H et al (1999) Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 42:886–893
Bae SH, Park W, Choi DH et al (2011) Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer. Radiat Oncol 6:52
Bhangu A, Ali SM, Cunningham D et al (2013) Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis 15:156–163
Haddock MG, Miller RC, Nelson H et al (2011) Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 79:143–150
Larsen SG, Wiig JN, Tretli S et al (2006) Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis 8:177–185
Willett CG, Gunderson LL (2004) Palliative treatment of rectal cancer: is radiotherapy alone a good option? J Gastrointest Surg 8:277-279
Lybeert MLM, Martijn H, DeNeve W et al (1992) Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: definite but limited influence of relapse free survival and survival. Int J Radiat Oncol Biol Phys 24:241–246
Guiney MJ, Smith JG, Worotniuk V et al (1997) Radiotherapy treatment for isolated locoregional recurrence of rectosigmoid cancer following definitive surgery: Peter MacCullum Cancer Institute experience, 1981–1990. Int J Radiat Oncol Biol Phys 38:1019–1025
Garcia-Aguilar J, Cromwell JW, Marra C et al (2001) Treatment of locally recurrent rectal cancer. Dis Colon Rectum 44:1743–1748
Asoglu O, Karanlik H, Muslumanoglu M et al (2007) Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 33:1199–1206
Yamada K, Ishizawa T, Niwa K et al (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88:988–993
Kanemitsu Y, Hirai T, Komori K et al (2010) Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer. Dis Colon Rectum 53:779–789
Vermaas M, Ferenschild FT, Nuyttens JJ et al (2005) Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 48:918–928
Weiser MR, Landmann RG, Wong WD et al (2005) Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 48:1169–1175
Kakuda JT, Lamont JP, Chu DZ et al (2003) The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 186:660–664
You YN, Habiba H, Chang GJ et al (2011) Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 18:989–996
Dresen RC, Gosens MJ, Martijn H et al (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947
Gagliardi G, Hawley PR, Hershman MJ et al (1995) Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 82:1401–1405
Shoup M, Guillem JG, Alektiar KM et al (2002) Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 45:585–592
Lopez-Kostner F, Fazio VW, Vignali A et al (2001) Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 44:173–178
Rödel C, Grabenbauer GG, Matzel KE et al (2000) Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 43:312–319
Maetani S, Onodera H, Nishikawa T (2007) Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Dis Colon Rectum 50:1558–1565
Melton GB, Paty PB, Boland PJ et al (2006) Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 49:1099–1107
Kusters M, Dresen RC, Martijn H et al (2009) Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 75:1444–1449
Sagar PM, Gonsalves S, Heath RM et al (2009) Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 96:191–196
Reerink O, Mulder NH, Botke G et al (2004) Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol 30:954–958
Rahbari NN, Ulrich AB, Bruckner T et al (2011) Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg 253:522–533
Bedrosian I, Giacco G, Pederson L et al (2006) Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49:175–182
Heriot AG, Byrne CM, Lee P et al (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51:284–291
Saito N, Koda K, Takiguchi N et al (2003) Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 20:192–199
Boyle KM, Sagar PM, Chalmers AG et al (2005) Surgery for locally recurrent rectal cancer. Dis Colon Rectum 48:929–937
Valentini V, Morganti AG, Gambacorta MA et al (2006) Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 64:1129–1139
Mohiuddin M, Marks G, Marks J (2002) Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 95:1144–1150
Wells BJ, Stotland P, Ko MA et al (2007) Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 14:390–395
Takagi H, Morimoto T, Hara S et al (1986) Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer. J Surg Oncol 32:184–188
Pearlman NW, Donohue RE, Stiegmann GV et al (1987) Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer. Arch Surg 122:537–541
Moriya Y, Akasu T, Fujita S et al (2004) Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 47:2047–2053
Lindel K, Willett CG, Shellito PC et al (2001) Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol 58:83–87
Mannaerts GH, Rutten HJ, Martijn H et al (2001) Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum 44:1749–1758
Mercantini P, Di Somma S, Magrini L et al (2012) Preoperative brain natriuretic peptide (BNP) is a better predictor of adverse cardiac events compared to preoperative scoring system in patients who underwent abdominal surgery. World J Surg 36:24–30
Wiig JN, Tveit KM, Poulsen JP et al (2002) Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 62:207–213
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Italia
About this chapter
Cite this chapter
La Torre, F., La Torre, M. (2016). Oncological Outcomes. In: Romano, G.M. (eds) Multimodal Treatment of Recurrent Pelvic Colorectal Cancer. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5767-8_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-5767-8_11
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5766-1
Online ISBN: 978-88-470-5767-8
eBook Packages: MedicineMedicine (R0)